Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-01-08 @ 9:37 PM
Study NCT ID:
NCT02383433
Status:
TERMINATED
Last Update Posted:
2023-10-23
First Post:
2015-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-04
First Submit QC Date:
None
Study First Post Date:
2015-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-22
Results First Submit QC Date:
None
Results First Post Date:
2019-05-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-16
Last Update Post Date:
2023-10-23
Last Update Post Date Type:
ACTUAL